This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): Varenicline, Champix, CP-526555
Description: Chantix is a partial agonist of the alpha4beta2 nicotinic acetylcholine receptor and a full agonist at the alpha7 nicotinic acetylcholine receptor. As their names imply, these receptors bind both the endogenous neurotransmitter acetylcholine and the exogenous drug nicotine.
Pink Sheet Chantix FDA Reviewers
Pink Sheet Chantix Clinical Development
Additional information available to subscribers only: